Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024)

Oculis Holding AG (OCS) posted quarterly Change in Account Payables of $2.5 million for Q4 2024, up 188.29% year-over-year from $851726.4 in Q1 2024, and up 23.68% quarter-over-quarter from $2.0 million in Q3 2024.

Analysis

Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024) Analysis & Trends

Oculis Holding AG's Change in Account Payables history runs 3 years deep, the most recent figure standing at $2.5 million for Q4 2024.

  • In Q4 2024, Change in Account Payables rose 188.29% year-over-year to $2.5 million; the TTM figure through Dec 2024 stood at -$514032.6 (down 200.93% YoY), while the FY2024 annual figure was -$429673.2, down 202.09% from the prior year.
  • Change in Account Payables for Q4 2024 stood at $2.5 million, up from $2.0 million in the prior quarter.
  • The five-year high for Change in Account Payables was $3.5 million in Q4 2022, with the low at -$7.4 million in Q1 2024.
  • The 3-year median for Change in Account Payables is $2.1 million (2023), against an average of $266803.2.
  • The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 527.44% in 2023, then tumbled 215.5% in 2024.
  • Oculis Holding AG's Change in Account Payables stood at $3.5 million in 2022, then sank by 180.36% to -$2.8 million in 2023, then surged by 188.29% to $2.5 million in 2024.
  • Business Quant data shows OCS's Change in Account Payables at $2.5 million in Q4 2024, $2.0 million in Q3 2024, and $2.4 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.46 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 2.40 Mn
Mar 31, 2024 -7.36 Mn
Dec 31, 2023 -2.78 Mn
Sep 30, 2023 3.37 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 -2.33 Mn
Dec 31, 2022 3.46 Mn
Sep 30, 2022 -787,982.50